RBS — Ramdevbaba Solvent Income Statement
0.000.00%
- IN₹2.71bn
- IN₹5.46bn
- IN₹9.29bn
- 20
- 60
- 58
- 43
Annual income statement for Ramdevbaba Solvent, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,239 | 5,829 | 6,978 | 6,864 | 9,287 |
Cost of Revenue | |||||
Gross Profit | 704 | 823 | 965 | 1,052 | 1,357 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,149 | 5,709 | 6,815 | 6,656 | 9,077 |
Operating Profit | 90.5 | 119 | 163 | 208 | 210 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 86 | 92 | 193 | 177 | 201 |
Provision for Income Taxes | |||||
Net Income After Taxes | 61.7 | 65.9 | 147 | 130 | 150 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 61.7 | 65.9 | 147 | 130 | 150 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 61.7 | 65.9 | 147 | 130 | 150 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.78 | 2.98 | 6.64 | 5.89 | 6.86 |
Dividends per Share |